Place an order request to the broker. The personal manager will contact you to confirm the order.

Order Summary

Asset: Select instrument
Quantity: -
Price per Unit: ? This price is indicative and shown for informational purposes only. The final execution price may change. -
Total Amount: -

Order Expiration

Order remains active until you cancel it or it gets filled

Order expires at the end of the selected day

Order Placed Successfully

Your order has been submitted! Our team will contact you shortly to confirm.

Order Type: -
Asset: -
Quantity: -
Total Amount: -
Manually record a past trade to keep your portfolio up to date. This helps track your P&L accurately.
Total Amount: $0.00

Trade Added Successfully

Trade recorded! Your portfolio data will be recalculated.

Type: -
Asset: -
Quantity: -
Price: -
Total: -

Chat Options

Web Search
Search the internet for recent information
Portfolio Context
Include your portfolio in the conversation
Market Data
Access real-time market information
Watchlist Context
Include your watchlist companies

Investment Managers Series Trus (IREX)

2026-10-08T13:51:00.706705+00:00

Key Updates

IREX extended its decline sharply, falling -13.33% since the last report (from $12.46 to $10.80), and is down -17.94% over the past five sessions alone. This move follows the -10.42% drop noted in the October 7 report, confirming a pattern of failed rebounds and accelerating downside momentum. There is no IREX-specific news driving this move; all available news items relate to the broader leveraged/inverse ETF industry rather than this fund directly, reinforcing that price action is being driven by the fund's underlying exposure and structural leverage mechanics rather than fundamental catalysts.

Current Trend

The trend remains firmly bearish and is deteriorating at an increasing rate across all timeframes: -8.72% (1d), -17.94% (5d), -40.34% (1m), -45.87% (6m), and -64.43% YTD. The brief two-session rebound from early October (+2.37% then +5.70%, taking the price from $12.86 to $13.91) has been fully erased and surpassed, with the price now roughly 22% below that recent local high. No stabilization or support level has held for more than one or two sessions; each prior "support" ($13.91, $12.46) has been breached within days. At $10.80, the fund is trading at fresh cycle lows with no technical floor established in the data provided.

Investment Thesis

IREX's price behavior — extreme volatility, repeated large single-day moves, and a YTD decline exceeding 64% — is consistent with a leveraged or inverse daily-reset product rather than a traditional equity holding. The broader industry context (new 2x/3x ETF and ETN launches, growing dealer swap activity, and simultaneous fund liquidations) confirms this is a fast-growing but high-risk segment where daily compounding can cause severe value erosion independent of the underlying's long-term direction. Any investment thesis must therefore rest on (a) a correct short-term directional view on the underlying/index, and (b) tolerance for path-dependent decay from daily resets, rather than a fundamental, buy-and-hold rationale.

Thesis Status

The thesis is being validated in the most negative sense: continued, accelerating losses with no durable reversal, consistent with the risk profile of leveraged/daily-reset products in adverse or volatile markets. The failure of the early-October rebound to hold materially weakens any near-term bullish thesis and confirms that this instrument is not suitable as a long-term holding. Confidence in a near-term recovery is low given the absence of fundamental support and the structural decay risk inherent to this product category.

Key Drivers

No company-specific catalysts were reported for IREX in this period. Sector-wide developments provide relevant context:

  • Tradr's liquidation of five leveraged/inverse ETFs (announced Oct 6, 2026) signals reduced investor demand and economic viability challenges for niche leveraged products, a relevant read-through for IREX given its similar structure.
  • Continued new issuance of 2x/3x leveraged and inverse products (MNGB, MNGZ, XLCU/XLCD/XLPU/XLPD) indicates a crowded, competitive segment with explicit issuer warnings about total-loss risk in volatile markets.
  • Jane Street's entry into leveraged ETF swaps ($1.2bn notional in Q2) confirms growing institutional infrastructure around these products, though this supports market liquidity rather than IREX's price direction specifically.

Technical Analysis

IREX is in a confirmed downtrend with accelerating momentum: the 1-day (-8.72%) and 5-day (-17.94%) declines are steeper than the 1-month pace would suggest, indicating the sell-off is intensifying rather than stabilizing. The price has broken below all recently established levels ($13.91, $12.86, $12.46) in succession, each of which failed to act as support. No new support level is evident in the current data; resistance now likely sits near the broken $12.46 level from the prior report. The pattern of sharp rebounds (+2.37%, +5.70%) being fully reversed by larger subsequent drops (-10.42%, -13.33%) suggests high volatility with a negative skew and no reliable reversal signal at this time.

Bull Case

  • Extreme oversold conditions after a cumulative ~65% YTD decline and a -17.94% five-day drop raise the statistical likelihood of a short-term technical bounce, though no fundamental catalyst currently supports this.
  • Growing institutional dealer participation in leveraged ETF swaps (Jane Street, Bloomberg) reflects improving market infrastructure and liquidity support for the broader leveraged ETF ecosystem.
  • Robust new product issuance across the leveraged/inverse ETF space (MNGZ, MNGB) signals continued investor demand for leveraged exposure strategies generally, which could support secondary market liquidity.
  • Expansion of sector-leveraged ETN coverage (XLC/XLP ETNs, BMO/REX Shares) demonstrates sustained industry-wide appetite for leveraged products, an indirect positive for category-wide trading volumes.
  • A sharp single-day decline of -8.72% following an already steep multi-week sell-off could reflect capitulation-type selling, historically a precursor (though not a guarantee) of near-term stabilization in highly leveraged instruments.

Bear Case

  • Tradr's liquidation of five comparable leveraged/inverse ETFs (PR Newswire) highlights waning demand and commercial unviability risk for niche leveraged products, a direct read-through risk for IREX.
  • Accelerating losses across all timeframes (-8.72% 1d, -17.94% 5d, -40.34% 1m, -64.43% YTD) show no sign of stabilization, with each short-term rebound fully reversed by larger subsequent declines.
  • Absence of any company-specific news or catalyst to explain the move suggests the decline is structural/mechanical (consistent with leveraged daily-reset decay) rather than tied to a recoverable fundamental event.
  • Industry-wide product warnings explicitly disclose that leveraged/inverse daily-target funds "could lose all or substantially all of their value in a single day" (MNGZ, MNGB), underscoring the structural fragility of this product category under volatile conditions.
  • Repeated failure of technical rebounds ($12.86→$13.16→$13.91, fully reversed to new lows at $10.80) indicates a broken trend structure with no durable support, increasing downside risk for continuation of the sell-off.
CapPilot is AI-powered and can make mistakes. Please double-check responses.

CapPilot leverages generative AI to distill market insights and analysis, as well as answer your questions in chat. While we work hard to ensure accuracy, AI-generated content may occasionally contain inaccuracies or outdated information.

We value your feedback — reporting errors helps us continuously improve.